Records containing: Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-04-19Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
-
CLINICAL_TRIALS study record update · 2013-04-17Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin: A 48-week Randomized, Open-label, Multicentre Phase IIIB Study to Compare the Effectiveness of Combination Therapy to Monotherapy in Type 2 Diabetes Mellitus Patients
-
CLINICAL_TRIALS study record update · 2013-04-16Protein Profile of Immunoregulatory Factors in Diabetic Cataract
-
CLINICAL_TRIALS study record update · 2013-04-16Cost Effectiveness of Glargine Insulin Versus NPH Insulin in Diabetic Patients in Iran
-
CLINICAL_TRIALS study record update · 2013-04-04A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of the Combination of SYR-322 (SYR110322) and Pioglitazone HCl (ACTOS®), in Subjects With Type 2 Diabetes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-04-02Effects of Glucose-dependent Insulinotropic Polypeptide at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2013-03-29Physical Activity for Overweight Youth at Risk for Type 2 Diabetes Mellitus (POWER) Trial
-
CLINICAL_TRIALS study record update · 2013-03-28A Multi-center, Open, Randomized, Parallel-group, 2 Arm Study to Compare the Efficacy and Safety of Amaryl®M 1/500mg Twice Daily Versus Amaryl® 4mg Both in Combination With Lantus® Once-daily Regimen in Type 2 Diabetes Mellitus Patients With Inadequate Glycemic Control
-
CLINICAL_TRIALS study record update · 2013-03-28A Multicenter, Randomized, Parallel-group, Open Study to Compare the Efficacy and Safety of Early Combination Therapy With Amaryl M to Metformin Uptitration in Type 2 DM Patients Inadequately Controlled on Metformin HCL
-
CLINICAL_TRIALS study record update · 2013-03-27Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2013-03-20An Open-Label Treatment Investigational New Drug (IND) for the Use of Generex Oral-lyn™ in Patients With Type 1 or Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2013-03-14Long Term Treatment With Exenatide Versus Glimepiride in Patients With Type 2 Diabetes Pretreated With Metformin (EUREXA: European Exenatide Study)
-
CLINICAL_TRIALS study record update · 2013-03-11Severe Insulin Resistance in Patients With Type 2 Diabetes: Mechanisms Behind Insulin Resistance.
-
CLINICAL_TRIALS study record update · 2013-03-05Proteus Sustained Behavior Change Study
-
CLINICAL_TRIALS study record update · 2013-02-27A Multicenter, Randomized, Active-controlled, Parallel-group Study to Assess the Efficacy and Safety of Insuman Comb 25 (Insulin Human) Versus Novolin® 30R Twice Daily Over 24 Weeks in Patients With Type 2 Diabetes Mellitus Who Are Under Insulin Therapy
-
CLINICAL_TRIALS study record update · 2013-02-21A Non Interventional, Cross Sectional, Epidemiological Study on the Management of Dyslipidemia in Type 2 DM Adult Patients in India
-
CLINICAL_TRIALS study record update · 2013-02-15Efficacy and Safety of CKD-501 or Pioglitazone Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: Multi Center, Randomized, Double Blind, Therapeutic Confirmatory Study
-
CLINICAL_TRIALS study record update · 2013-02-13NOX-E36 - A Phase Ib, Multiple Intravenous Dose Study to Evaluate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties in Healthy Subjects and Then in Three Groups of Patients With Type 2 Diabetes Mellitus to Compare Three Ascending Dose Regimens in a Double-blind and Placebo-controlled Manner
-
CLINICAL_TRIALS study record update · 2013-02-13NOX-E36 - A Phase I, Double-Blind, Placebo Controlled, Single Intravenous and Subcutaneous Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2013-02-08Observational Study of Diurnal Triglyceridemia in Relation to Alcohol Intake
-
CLINICAL_TRIALS study record update · 2013-02-05Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2013-01-30A Multicenter, Open-label, Single-arm, 24 Week Phase IV Study Evaluating the Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure
-
CLINICAL_TRIALS study record update · 2013-01-29Interactions Between Exogenous Insulin Aspart, Endogenous Insulin and Plasma Glucose in Type 2 Diabetes Mellitus Patients
-
CLINICAL_TRIALS study record update · 2013-01-15The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 DiabetesS
-
CLINICAL_TRIALS study record update · 2013-01-09ClinicalTrials.gov study NCT00901979